Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens 2026-20727 | Food and Drug Administration | Final rule | Oct 9 |
Medical Devices; Cardiovascular Devices; Classification of the Infant Pulse Rate and Oxygen Saturation Monitor for Over-the-Counter Use 2026-20726 | Food and Drug Administration | Final rule | Oct 9 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Hematopoietic Cell Enrichment Kit 2026-20725 | Food and Drug Administration | Final rule | Oct 9 |
Medical Devices; Exemptions From Premarket Notification: Class II Devices; Certain Clinical Toxicology Test Systems 2026-20448 | Food and Drug Administration | Final rule | Oct 6 |
Medical Devices; Immunology and Microbiology Devices; Classification of the High Throughput DNA Sequencing for Hereditary Cancer Predisposition Assessment Test System 2026-20443 | Food and Drug Administration | Final rule | Oct 6 |
Medical Devices; Cardiovascular Devices; Classification of the Hyperoxia Monitoring Device Adjunct to Pulse Oximetry 2026-20441 | Food and Drug Administration | Final rule | Oct 6 |
Medical Devices; General and Plastic Surgery Devices; Classification of the Focused Ultrasound System for Non-Thermal, Mechanical Tissue Ablation 2026-20440 | Food and Drug Administration | Final rule | Oct 6 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Flushing and Storage Solution for Vascular Autografts at Room Temperature 2026-20075 | Food and Drug Administration | Final rule | Sep 30 |
Medical Devices; Cardiovascular Devices; Classification of the Cardiovascular Machine Learning-Based Notification Software 2026-18612 | Food and Drug Administration | Final rule | Sep 11 |
Medical Devices; Cardiovascular Devices; Classification of the Mechanical Deviation Device for Esophageal Protection During Cardiac Ablation Procedures 2026-18433 | Food and Drug Administration | Final rule | Sep 10 |
Medical Devices; Cardiovascular Devices; Classification of the Temperature Regulation Device for Esophageal Protection During Cardiac Ablation Procedures 2026-18432 | Food and Drug Administration | Final rule | Sep 10 |
Medical Devices; Cardiovascular Devices; Classification of the Extravascular Support for an Arteriovenous Fistula for Vascular Access 2026-18431 | Food and Drug Administration | Final rule | Sep 10 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Anti-Tumor Necrosis Factor Alpha Monoclonal Antibody Test System for Inflammatory Bowel Disease 2026-18430 | Food and Drug Administration | Final rule | Sep 10 |
Medical Devices; Ear, Nose, and Throat Devices; Classification of the Cooperative Powered Surgical Assist Device for ENT Surgery 2026-18429 | Food and Drug Administration | Final rule | Sep 10 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Implanted Tibial Electrical Urinary Continence Device 2026-18428 | Food and Drug Administration | Final rule | Sep 10 |
Medical Devices; Radiology Devices; Classification of the Vaginal Hydrogel Packing System 2026-18427 | Food and Drug Administration | Final rule | Sep 10 |
Medical Devices; General Hospital and Personal Use Devices; Classification of the Whole Room Microbial Reduction Device 2026-18426 | Food and Drug Administration | Final rule | Sep 10 |
Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended as an Aid for Detection of Bladder Cancer 2026-16728 | Food and Drug Administration | Proposed rule | Aug 17 |
Hematology and Pathology Devices; Reclassification of In Situ Hybridization Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product 2026-16727 | Food and Drug Administration | Final rule | Aug 17 |
Radiology Devices; Reclassification of Digital Breast Tomosynthesis System 2026-16209 | Food and Drug Administration | Proposed rule | Aug 10 |
Medical Devices; Radiology Devices; Classification of the Fludeoxyglucose F18-Guided Radiation Therapy System 2026-15963 | Food and Drug Administration | Final rule | Aug 6 |
Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals (IPPS) and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year (FY) 2027 Rates; Requirements for Quality Programs; Other Policy Changes; and Adoption of Updated Versions of Certain Health Information Technology Standards 2026-15833 | Centers for Medicare & Medicaid Services | Final rule | Aug 4 |
Medical Devices; Radiology Devices; Classification of the Phase-Changing Fiducial Marker for Radiation Therapy 2026-15303 | Food and Drug Administration | Final rule | Jul 29 |
Rescission of Outdated Veterans Choice Program Regulations 2026-15210 | Veterans Affairs Department | Final rule | Jul 28 |
Reducing Barriers to Medical Use Licensing 2026-15080 | Nuclear Regulatory Commission | Proposed rule | Jul 27 |
Medical Devices; General Hospital and Personal Use Devices; Classification of the Active Noise Attenuation System for Infant Incubators 2026-15075 | Food and Drug Administration | Final rule | Jul 27 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Non-Medicated Topical Formulation for Treatment of Erectile Dysfunction 2026-15074 | Food and Drug Administration | Final rule | Jul 27 |
Medical Devices; Orthopedic Devices; Classification of the Intraoperative Surgical Angle Measurement Tool 2026-14987 | Food and Drug Administration | Final rule | Jul 24 |
Medical Devices; General Hospital and Personal Use Devices; Classification of the Diabetes Digital Behavioral Therapeutic Device 2026-14986 | Food and Drug Administration | Final rule | Jul 24 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Over-the-Counter Test To Detect SARS-CoV-2 From Clinical Specimens 2026-14985 | Food and Drug Administration | Final rule | Jul 24 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Prognostic Test for Assessment of Chronic Kidney Disease Progression 2026-14984 | Food and Drug Administration | Final rule | Jul 24 |
Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program 2026-14327 | Centers for Medicare & Medicaid Services | Proposed rule | Jul 16 |
Reforming and Modernizing the NRC's Radiation Protection Framework 2026-14208 | Nuclear Regulatory Commission | Proposed rule | Jul 15 |
Expansion of VA Process for 72-Hour Notification of Emergency Treatment 2026-13971 | Veterans Affairs Department | Final rule | Jul 10 |
Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies 2026-13602 | Centers for Medicare & Medicaid Services | Proposed rule | Jul 6 |
Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of Oxygenation 2026-13140 | Food and Drug Administration | Final rule | Jun 30 |
Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of Hyperhidrosis 2026-13139 | Food and Drug Administration | Final rule | Jun 30 |
Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock Absorber 2026-13101 | Food and Drug Administration | Final rule | Jun 29 |
Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep System 2026-12905 | Food and Drug Administration | Final rule | Jun 26 |
Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs Syndrome 2026-12904 | Food and Drug Administration | Final rule | Jun 26 |
Medical Devices; General and Plastic Surgery Devices; Classification of the Breast Implant Suction Retrieval System 2026-12903 | Food and Drug Administration | Final rule | Jun 26 |
Medical Devices; Immunology and Microbiology Devices; Classification of the SARS-CoV-2 Serology Test 2026-12902 | Food and Drug Administration | Final rule | Jun 26 |
Medical Devices; Neurological Devices; Classification of the Computerized Behavioral Therapy Device for the Treatment of Fibromyalgia Symptoms 2026-12901 | Food and Drug Administration | Final rule | Jun 26 |
Medical Devices; Clinical Chemistry and Toxicology Devices; Classification of the Prognostic Test for Development or Progression of Preeclampsia 2026-12900 | Food and Drug Administration | Final rule | Jun 26 |
Medical Devices; General Hospital and Personal Use Devices; Classification of the Foam or Gel Chemical Sterilant/High Level Disinfectant 2026-12899 | Food and Drug Administration | Final rule | Jun 26 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic Traction Device 2026-12445 | Food and Drug Administration | Final rule | Jun 22 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic Light-Projecting Measuring Device 2026-12444 | Food and Drug Administration | Final rule | Jun 22 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Simple In Vitro Diagnostic Device for the Detection of Secreted Proteins From Bacillus Species (spp.) in Human Clinical Samples 2026-12443 | Food and Drug Administration | Final rule | Jun 22 |
Medical Devices; Radiology Devices; Classification of the Radiological Machine Learning-Based Quantitative Imaging Software With Predetermined Change Control Plan 2026-12166 | Food and Drug Administration | Final rule | Jun 17 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Ingestible Gastrointestinal Blood Detection Capsule 2026-12165 | Food and Drug Administration | Final rule | Jun 17 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Spinal Muscular Atrophy Newborn Screening Test System 2026-11740 | Food and Drug Administration | Final rule | Jun 11 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS-CoV-2 Viral Targets From Clinical Specimens in Near-Patient Settings 2026-11739 | Food and Drug Administration | Final rule | Jun 11 |
Medical Devices; Ear, Nose, and Throat Devices; Classification of the Combined Acoustic and Electrical External Stimulation Device for the Relief of Tinnitus 2026-11589 | Food and Drug Administration | Final rule | Jun 10 |
Medical Devices; Orthopedic Devices; Classification of the Resorbable Calcium Salt Bone Void Filler Containing a Single Approved Aminoglycoside Antibacterial 2026-11308 | Food and Drug Administration | Final rule | Jun 5 |
Medical Devices; Orthopedic Devices; Classification of the Shoulder Joint Humeral (Hemi-Shoulder) Ceramic Head/Metallic Stem Cemented or Uncemented Prosthesis 2026-11306 | Food and Drug Administration | Final rule | Jun 5 |
Medical Devices; Orthopedic Devices; Classification of the Absorbable Metallic Bone Fixation Fastener 2026-11302 | Food and Drug Administration | Final rule | Jun 5 |
Medical Devices; General Hospital and Personal Use Devices; Classification of the Rigid Sterilization Container With Electronic Monitoring 2026-10908 | Food and Drug Administration | Final rule | Jun 1 |
Medical Devices; Anesthesiology Devices; Classification of the Real-Time Ultrasound Anatomy Visualization and Labeling Device for Ultrasound Guided Regional Anesthesia 2026-10907 | Food and Drug Administration | Final rule | Jun 1 |
Medical Devices; Anesthesiology Devices; Classification of the Adjunctive Pain Measurement Device for Anesthesiology 2026-10905 | Food and Drug Administration | Final rule | Jun 1 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Orally Ingested Transient Device for Constipation 2026-10904 | Food and Drug Administration | Final rule | Jun 1 |
Medical Devices; Dental Devices; Classification of the Intraoral Cooling Device 2026-10899 | Food and Drug Administration | Final rule | Jun 1 |
Medical Devices; Hematology and Pathology Devices; Classification of the Von Willebrand Factor Assay 2026-10898 | Food and Drug Administration | Final rule | Jun 1 |
Medical Devices; Ear, Nose, and Throat Devices; Classification of the Oropharyngeal Electrical Stimulator 2026-10894 | Food and Drug Administration | Final rule | Jun 1 |
Medical Devices; Neurological Devices; Classification of the Transcutaneous Electrical Nerve Stimulator To Treat Fibromyalgia Symptoms 2026-10675 | Food and Drug Administration | Final rule | May 29 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic Suturing Device for Altering Gastric Anatomy for Weight Loss 2026-10621 | Food and Drug Administration | Final rule | May 28 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microorganism Nucleic Acids and Resistance Markers From Patients With Suspected Orthopedic Infection 2026-09335 | Food and Drug Administration | Final rule | May 12 |
Medical Devices; Obstetrical and Gynecological Devices; Classification of the External Condom for Anal Intercourse or Vaginal Intercourse 2026-09152 | Food and Drug Administration | Final rule | May 8 |
Modification of Certain Terminology in Title 21 2026-08826 | Food and Drug Administration | Proposed rule | May 6 |
Medical Devices; Ophthalmic Devices; Classification of the Corneal Storage Medium With Preservatives Including Antifungals 2026-08813 | Food and Drug Administration | Final rule | May 6 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Circulating Tumor Cell Enrichment Device 2026-08812 | Food and Drug Administration | Final rule | May 6 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Preserve and Stabilize Relative Abundances of Microbial Nucleic Acids in Clinical Samples 2026-08811 | Food and Drug Administration | Final rule | May 6 |
Medical Devices; General and Plastic Surgery Devices; Classification of the Phototherapy Device for Reducing the Appearance of Acute Post-Surgical Incisions 2026-08497 | Food and Drug Administration | Final rule | May 1 |
Medical Devices; Cardiovascular Devices; Classification of the Laser-Powered Inferior Vena Cava Filter Retrieval Catheter 2026-08426 | Food and Drug Administration | Final rule | Apr 30 |
Medical Devices; Neurological Devices; Classification of the Brain Temperature Measurement System 2026-08425 | Food and Drug Administration | Final rule | Apr 30 |
Medical Devices; Radiology Devices; Classification of the Radiation Therapy Marking Device 2026-08424 | Food and Drug Administration | Final rule | Apr 30 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Setmelanotide Eligibility Gene Variant Detection System 2026-07863 | Food and Drug Administration | Final rule | Apr 22 |
Medical Devices; Anesthesiology Devices; Classification of the Device for Sleep Apnea Testing Based on Mandibular Movement 2026-07862 | Food and Drug Administration | Final rule | Apr 22 |
Medical Devices; Ophthalmic Devices; Classification of the Digital Therapy Device for Amblyopia 2026-07861 | Food and Drug Administration | Final rule | Apr 22 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Alzheimer's Disease Pathology Assessment Test 2026-07860 | Food and Drug Administration | Final rule | Apr 22 |
Medical Devices; Orthopedic Devices; Classification of the Manual Surgical Instrument for Appropriate Patient Selection for Orthopedic Implant 2026-07367 | Food and Drug Administration | Final rule | Apr 16 |
Physical Medicine Devices; Reclassification of Non-Invasive Bone Growth Stimulators 2026-07366 | Food and Drug Administration | Final rule | Apr 16 |
Medical Devices; Ear, Nose, and Throat Devices; Classification of the Transcutaneous Electrical Nerve Stimulator for the Relief of Congestion 2026-07365 | Food and Drug Administration | Final rule | Apr 16 |
Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals (IPPS) and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year (FY) 2027 Rates; Requirements for Quality Programs; and Other Policy Changes 2026-07203 | Centers for Medicare & Medicaid Services | Proposed rule | Apr 14 |
Microbiology Devices; Reclassification of Mycobacterium Tuberculosis Cell-Mediated Immunity Tests and Immune Response Enzyme-Linked Immunospot Tests 2026-06064 | Food and Drug Administration | Proposed rule | Mar 30 |
General and Plastic Surgery Devices; Reclassification of Optical Diagnostic Devices for Melanoma Detection and Electrical Impedance Spectrometers, To Be Renamed Software-Aided Adjunctive Diagnostic Devices for Use on Skin Lesions by Physicians Trained in the Diagnosis and Management of Skin Cancer 2026-05772 | Food and Drug Administration | Final rule | Mar 25 |
Effective Date of Requirement for Premarket Approval Applications for Blood Irradiators Intended To Prevent Metastasis 2026-05322 | Food and Drug Administration | Proposed rule | Mar 18 |
Medical Devices; Radiology Devices; Classification of Blood Irradiators 2026-05320 | Food and Drug Administration | Proposed rule | Mar 18 |
Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction 2026-04797 · significant | Centers for Medicare & Medicaid Services | Final rule | Mar 12 |
Listing of Color Additives Exempt From Certification; Spirulina Extract 2026-02314 | Food and Drug Administration | Final rule | Feb 6 |
Listing of Color Additives Exempt From Certification; Beetroot Red 2026-02313 | Food and Drug Administration | Final rule | Feb 6 |
Delete, Delete, Delete 2026-01442 | Federal Communications Commission | Final rule | Jan 26 |
Medical Devices; Neurological Devices; Classification of the Electrical Tongue Nerve Stimulator To Treat Motor Deficits 2025-23413 | Food and Drug Administration | Final rule | Dec 19, 2025 |
Medical Devices; Quality Management System Regulation Technical Amendments 2025-21955 | Food and Drug Administration | Final rule | Dec 4, 2025 |
The Sunset Rule 2025-21784 · significant | Nuclear Regulatory Commission | Final rule | Dec 3, 2025 |
Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies 2025-21767 · significant | Centers for Medicare & Medicaid Services | Final rule | Dec 2, 2025 |
Medical Devices; Neurological Devices; Classification of Field Generator Positioning Device 2025-21218 | Food and Drug Administration | Final rule | Nov 26, 2025 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Anchored Esophageal Sheath 2025-21217 | Food and Drug Administration | Final rule | Nov 26, 2025 |
Immunology and Microbiology Devices; Reclassification of Nucleic Acid-Based Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product; Proposed Amendment; Proposed Order; Request for Comments 2025-21071 | Food and Drug Administration | Proposed rule | Nov 25, 2025 |
Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program 2025-19787 · significant | Centers for Medicare & Medicaid Services | Final rule | Nov 5, 2025 |
Health Care Professionals Practicing Via Telehealth 2025-19324 · significant | Veterans Affairs Department | Final rule | Oct 2, 2025 |
Listing of Color Additives Exempt From Certification; Gardenia (Genipin) Blue; Confirmation of Effective Date 2025-19166 | Food and Drug Administration | Final rule | Oct 1, 2025 |
Regulation Identification Number 0910-AJ05 Medical Devices; Laboratory Developed Tests; Implementation of Vacatur 2025-18239 | Food and Drug Administration | Final rule | Sep 19, 2025 |
Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices 2025-18082 | Food and Drug Administration | Final rule | Sep 18, 2025 |
Listing of Color Additives Exempt From Certification; Calcium Phosphate; Confirmation of Effective Date 2025-16047 | Food and Drug Administration | Final rule | Aug 21, 2025 |
Listing of Color Additives Exempt From Certification; Galdieria Extract Blue; Confirmation of Effective Date 2025-16046 | Food and Drug Administration | Final rule | Aug 21, 2025 |
Listing of Color Additives Exempt From Certification; Butterfly Pea Flower Extract; Confirmation of Effective Date 2025-16045 | Food and Drug Administration | Final rule | Aug 21, 2025 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Laparoscopic Gastrointestinal Sizing Tool 2025-16041 | Food and Drug Administration | Final rule | Aug 21, 2025 |
Medical Devices; Orthopedic Devices; Classification of Orthopedic Manual Surgical Instrumentation for Use With Non-Fusion Spinous Process Spacer Devices 2025-16040 | Food and Drug Administration | Final rule | Aug 21, 2025 |
Medical Devices; Orthopedic Devices; Classification of Orthopedic Manual Surgical Instrumentation for Use With Total Disc Replacement Devices 2025-16039 | Food and Drug Administration | Final rule | Aug 21, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Mutation Detection Test for Myeloproliferative Neoplasms 2025-16038 | Food and Drug Administration | Final rule | Aug 21, 2025 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Pharmacogenetic Assessment System 2025-16037 | Food and Drug Administration | Final rule | Aug 21, 2025 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Menopause Test System 2025-16036 | Food and Drug Administration | Final rule | Aug 21, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Cancer Predisposition Risk Assessment System 2025-16035 | Food and Drug Administration | Final rule | Aug 21, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of A Multiplex Respiratory Panel To Detect and Identify Emerging Respiratory Pathogen(s) and Common Respiratory Pathogens in Human Clinical Specimens 2025-16034 | Food and Drug Administration | Final rule | Aug 21, 2025 |
Medical Devices; Radiology Devices; Classification of the Liver Iron Concentration Imaging Companion Diagnostic for Deferasirox 2025-16033 | Food and Drug Administration | Final rule | Aug 21, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Postnatal Chromosomal Copy Number Variation Detection System 2025-16032 | Food and Drug Administration | Final rule | Aug 21, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Anti-Phospholipase A2 Receptor Immunological Test System 2025-16031 | Food and Drug Administration | Final rule | Aug 21, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device That Detects Nucleic Acid Sequences From Microorganisms Associated With Vaginitis and Bacterial Vaginosis 2025-16030 | Food and Drug Administration | Final rule | Aug 21, 2025 |
Reproductive Health Services 2025-14687 · significant | Veterans Affairs Department | Proposed rule | Aug 4, 2025 |
Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program 2025-13271 · significant | Centers for Medicare & Medicaid Services | Proposed rule | Jul 16, 2025 |
Listing of Color Additives Exempt From Certification; Gardenia (Genipin) Blue 2025-13175 | Food and Drug Administration | Final rule | Jul 15, 2025 |
Medicare and Medicaid Programs; Calendar Year 2026 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the HH Value-Based Purchasing Expanded Model; Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program Updates; DMEPOS Accreditation Requirements; Provider Enrollment; and Other Medicare and Medicaid Policies 2025-12347 · significant | Centers for Medicare & Medicaid Services | Proposed rule | Jul 2, 2025 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Muscular Dystrophy Newborn Screening Test 2025-11796 | Food and Drug Administration | Final rule | Jun 26, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Herpes Simplex Virus Nucleic Acid-Based Assay for Central Nervous System Infections 2025-11794 | Food and Drug Administration | Final rule | Jun 26, 2025 |
Medical Devices; Hematology and Pathology Devices; Classification of the Fluorescence In Situ Hybridization-Based Detection of Chromosomal Abnormalities From Patients With Hematologic Malignancies 2025-11793 | Food and Drug Administration | Final rule | Jun 26, 2025 |
Medical Devices; Radiology Devices; Classification of the Cream for X-Ray Attenuation 2025-11791 | Food and Drug Administration | Final rule | Jun 26, 2025 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Lysosomal Storage Disorder Newborn Screening Test System 2025-11781 | Food and Drug Administration | Final rule | Jun 26, 2025 |
Medical Devices; Exemptions From Premarket Notification: Class II Devices; Clinical Electronic Thermometers 2025-11207 | Food and Drug Administration | Final rule | Jun 18, 2025 |
Medical Devices; Radiology Devices; Classification of the Radiological Computer-Assisted Detection and Diagnosis Software 2025-10789 | Food and Drug Administration | Final rule | Jun 13, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Clinical Mass Spectrometry Microorganism Identification and Differentiation System 2025-10788 | Food and Drug Administration | Final rule | Jun 13, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Cellular Analysis System for Multiplexed Antimicrobial Susceptibility Testing 2025-10787 | Food and Drug Administration | Final rule | Jun 13, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Fungal Nucleic Acids Directly in Respiratory Specimens 2025-10786 | Food and Drug Administration | Final rule | Jun 13, 2025 |
Hematology and Pathology Devices; Reclassification of In Situ Hybridization Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product 2025-10549 | Food and Drug Administration | Proposed rule | Jun 11, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect Bacterial Protease Activity in Chronic Wound Fluid 2025-09883 | Food and Drug Administration | Final rule | Jun 2, 2025 |
Medical Devices; Radiology Devices; Classification of the Radiological Acquisition and/or Optimization Guidance System 2025-09837 | Food and Drug Administration | Final rule | Jun 2, 2025 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Anti-Mullerian Hormone Test System 2025-09776 | Food and Drug Administration | Final rule | May 30, 2025 |
Listing of Color Additives; Myoglobin; Confirmation of Effective Date 2025-09680 | Food and Drug Administration | Final rule | May 29, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Inherited Nucleotide Repeat Disorder Deoxyribonucleic Acid Test 2025-09641 | Food and Drug Administration | Final rule | May 29, 2025 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Temporarily-Placed Urethral Opening System for Symptoms of Benign Prostatic Hyperplasia 2025-09640 | Food and Drug Administration | Final rule | May 29, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Zika Virus Serological Reagents 2025-09639 | Food and Drug Administration | Final rule | May 29, 2025 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Plazomicin Test System 2025-09638 | Food and Drug Administration | Final rule | May 29, 2025 |
Medicare and Medicaid Programs; CY 2025 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Medicare Prescription Drug Inflation Rebate Program; and Medicare Overpayments; and Appeal Rights for Certain Changes in Patient Status; Corrections and Correcting Amendment 2025-08676 | Centers for Medicare & Medicaid Services | Final rule | May 16, 2025 |
Listing of Color Additives Exempt From Certification; Galdieria Extract Blue 2025-08250 | Food and Drug Administration | Final rule | May 12, 2025 |
Listing of Color Additives Exempt From Certification; Calcium Phosphate 2025-08249 | Food and Drug Administration | Final rule | May 12, 2025 |
Listing of Color Additives Exempt From Certification; Butterfly Pea Flower Extract 2025-08248 | Food and Drug Administration | Final rule | May 12, 2025 |
Medical Devices; Hematology and Pathology Devices; Classification of the Coagulation System for the Measurement of Whole Blood Viscoelastic Properties in Perioperative Patients 2025-08151 | Food and Drug Administration | Final rule | May 9, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microbial Nucleic Acids by Fluorescence In Situ Hybridization in Clinical Specimens 2025-08150 | Food and Drug Administration | Final rule | May 9, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect Nucleic Acids From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections and Associated Resistance Marker(s) 2025-08149 | Food and Drug Administration | Final rule | May 9, 2025 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Voriconazole Test System 2025-08148 | Food and Drug Administration | Final rule | May 9, 2025 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Breast Milk Macronutrients Test System 2025-08147 | Food and Drug Administration | Final rule | May 9, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Cytomegalovirus Nucleic Acid Detection Device for Congenital Cytomegalovirus Infection 2025-08146 | Food and Drug Administration | Final rule | May 9, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Microbial Nucleic Acid Storage and Stabilization Device 2025-08145 | Food and Drug Administration | Final rule | May 9, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Measure Non-Microbial Analytes To Aid in the Detection and Identification of Localized Human Infections 2025-08144 | Food and Drug Administration | Final rule | May 9, 2025 |
Medical Devices; Immunology and Microbiology Devices; Classification of the DNA-Based Test To Measure Minimal Residual Disease in Hematological Malignancies 2025-08143 | Food and Drug Administration | Final rule | May 9, 2025 |
Listing of Color Additives Exempt From Certification; Myoglobin 2025-01239 | Food and Drug Administration | Final rule | Jan 17, 2025 |
Medicare Program: Appeal Rights for Certain Changes in Patient Status and Changes to the Medicare Claims and Medicare Prescription Drug Coverage Determination Appeals Procedures; Correcting Amendment 2024-31146 | Centers for Medicare & Medicaid Services | Final rule | Dec 30, 2024 |
Clinical Trials Registration and Results Information Submission 2024-28475 | Health and Human Services Department | Final rule | Dec 9, 2024 |
Medicare and Medicaid Programs; CY 2025 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Medicare Prescription Drug Inflation Rebate Program; and Medicare Overpayments 2024-25382 · significant | Centers for Medicare & Medicaid Services | Final rule | Dec 9, 2024 |
Medicare Program: Appeal Rights for Certain Changes in Patient Status 2024-23195 · significant | Centers for Medicare & Medicaid Services | Final rule | Oct 15, 2024 |
Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices 2024-21932 | Food and Drug Administration | Proposed rule | Sep 25, 2024 |
Microbiology Devices; Reclassification of Cytomegalovirus Deoxyribonucleic Acid Quantitative Assay Devices Intended for Transplant Patient Management 2024-21616 | Food and Drug Administration | Final rule | Sep 23, 2024 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Quantitative Viral Nucleic Acid Test for Transplant Patient Management 2024-21086 | Food and Drug Administration | Final rule | Sep 17, 2024 |
Medical Devices; Therapeutic Devices; Classification of the Pediatric Continuous Renal Replacement Therapy System 2024-20999 | Food and Drug Administration | Final rule | Sep 16, 2024 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect or Measure Nucleic Acid From Viruses Associated With Head and Neck Cancers 2024-20896 | Food and Drug Administration | Final rule | Sep 16, 2024 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Clozapine Test System 2024-20895 | Food and Drug Administration | Final rule | Sep 16, 2024 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Whole Exome Sequencing Constituent Device 2024-20550 | Food and Drug Administration | Final rule | Sep 11, 2024 |
Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Blood Collection Device for Cell-Free Nucleic Acids 2024-20254 | Food and Drug Administration | Final rule | Sep 9, 2024 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic Pancreatic Debridement Device 2024-20248 | Food and Drug Administration | Final rule | Sep 9, 2024 |
Medical Devices; Gastroenterology-Urology Devices; Classification of the Hemodialyzer With Expanded Solute Removal Profile 2024-20081 | Food and Drug Administration | Final rule | Sep 6, 2024 |
Medical Devices; Ophthalmic Devices; Classification of the Hydrophilic Re-Coating Solution 2024-19882 | Food and Drug Administration | Final rule | Sep 5, 2024 |
Medical Devices; Dental Devices; Classification of the Radiofrequency Toothbrush 2024-19868 | Food and Drug Administration | Final rule | Sep 5, 2024 |
Medical Devices; Hematology and Pathology Devices; Classification of the Heparin and Direct Oral Factor Xa Inhibitor Drug Test System 2024-19824 | Food and Drug Administration | Final rule | Sep 5, 2024 |
Medical Devices; Cardiovascular Devices; Classification of the Adjunctive Open Loop Fluid Therapy Recommender 2024-19736 | Food and Drug Administration | Final rule | Sep 5, 2024 |
Medical Devices; Orthopedic Devices; Classification of the Intervertebral Body Graft Containment Device 2024-19726 | Food and Drug Administration | Final rule | Sep 3, 2024 |
Medical Devices; Dental Devices; Classification of the Neuromuscular Tongue Muscle Stimulator for the Reduction of Snoring and Obstructive Sleep Apnea 2024-19725 | Food and Drug Administration | Final rule | Sep 3, 2024 |
Medical Devices; Physical Medicine Devices; Classification of the External Compression Device for Internal Jugular Vein Compression 2024-19722 | Food and Drug Administration | Final rule | Sep 3, 2024 |
Medical Devices; Neurological Devices; Classification of the Digital Therapy Device for Attention Deficit Hyperactivity Disorder 2024-19720 | Food and Drug Administration | Final rule | Sep 3, 2024 |
Medicare and Medicaid Programs and the Children's Health Insurance Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2025 Rates; Quality Programs Requirements; and Other Policy Changes 2024-17021 | Centers for Medicare & Medicaid Services | Final rule | Aug 28, 2024 |
Medical Devices; General Hospital and Personal Use Devices; Classification of the Intravenous Catheter Force-Activated Separation Device 2024-18267 | Food and Drug Administration | Final rule | Aug 16, 2024 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Nucleic Acid Targets Including SARS-CoV-2 in Respiratory Specimens 2024-18266 | Food and Drug Administration | Final rule | Aug 16, 2024 |
Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Selected Microbial Agents That Cause Acute Febrile Illness 2024-18264 | Food and Drug Administration | Final rule | Aug 16, 2024 |
Medicare and Medicaid Programs; CY 2025 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Medicare Prescription Drug Inflation Rebate Program; and Medicare Overpayments 2024-14828 | Centers for Medicare & Medicaid Services | Proposed rule | Jul 31, 2024 |
Center for Innovation for Care and Payment Update 2024-16601 | Veterans Affairs Department | Final rule | Jul 29, 2024 |
Ophthalmic Practice Rules (Eyeglass Rule) 2024-15620 | Federal Trade Commission | Final rule | Jul 26, 2024 |
Standards for Accessible Medical Diagnostic Equipment 2024-16266 | Architectural and Transportation Barriers Compliance Board | Final rule | Jul 25, 2024 |
Current Good Manufacturing Practice, Certification, Postmarketing Safety Reporting, and Labeling Requirements for Certain Medical Gases 2024-13190 | Food and Drug Administration | Final rule | Jun 18, 2024 |
Adaptive Equipment Allowance 2024-13116 | Veterans Affairs Department | Final rule | Jun 17, 2024 |
Ophthalmic Devices; Reclassification of Ultrasound Cyclodestructive Device 2024-10895 | Food and Drug Administration | Final rule | May 20, 2024 |
Medical Devices; Laboratory Developed Tests 2024-08935 | Food and Drug Administration | Final rule | May 6, 2024 |
Medicare and Medicaid Programs and the Children's Health Insurance Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2025 Rates; Quality Programs Requirements; and Other Policy Changes 2024-07567 | Centers for Medicare & Medicaid Services | Proposed rule | May 2, 2024 |
CHAMPVA Coverage of Audio-Only Telehealth, Mental Health Services, and Cost Sharing for Certain Contraceptive Services and Contraceptive Products Approved, Cleared, or Granted by FDA 2024-09072 · significant | Veterans Affairs Department | Final rule | Apr 30, 2024 |
Banned Devices; Proposal To Ban Electrical Stimulation Devices for Self-Injurious or Aggressive Behavior 2024-06037 | Food and Drug Administration | Proposed rule | Mar 26, 2024 |
Medical Devices; Technical Amendments 2024-05473 | Food and Drug Administration | Final rule | Mar 15, 2024 |
Reproductive Health Services 2024-04275 · significant | Veterans Affairs Department | Final rule | Mar 4, 2024 |
North Korea Sanctions Regulations 2024-03255 | Foreign Assets Control Office | Final rule | Feb 16, 2024 |
Beneficiary Travel and Special Mode Transportation Under 38 U.S.C. 111 Within the United States 2024-03127 · significant | Veterans Affairs Department | Final rule | Feb 15, 2024 |
Medical Devices; Quality System Regulation Amendments 2024-01709 | Food and Drug Administration | Final rule | Feb 2, 2024 |
Listing of Color Additives Exempt From Certification; Jagua (Genipin-Glycine) Blue; Confirmation of Effective Date 2024-01106 | Food and Drug Administration | Final rule | Jan 23, 2024 |